|
- Drossman DA. Functional abdominal pain syndrome. Clin Gastroenterol Hepatol 2004;2:353–365.
- Drossman DA. Presidential address: gastrointestinal illness and the biopsychosocial model. Psychosom Med 1998;60:258–267.
- Whorwell P, Keefer L, Drossman DA, Guthrie E, et al. Centrally mediated disorders of gastrointestinal pain. In: Drossman DA, Chang L, Chey WD, Kellow J, Tack J, Whitehead WE (eds). Rome IV Functional Gastrointestinal Disorders—Disorders of Gut-Brain Interaction, 4th edition. Raleigh, NC: Rome Foundation, 2016; pp. 1059–1116.
- Maxton DG, Whorwell PJ. Use of medical resources and attitudes to health care of patients with ‘chronic abdominal pain’. Brit J Med Econ 1992;2:75–79.
- Dorn SD, Palsson OS, Thiwan SI, et al. Increased colonic pain sensitivity in irritable bowel syndrome is the result of an increased tendency to report pain rather than increased neurosensory sensitivity. Gut 2007;56:1202–1209.
- Tillisch K, Mayer EA, Labus JS. Quantitative meta-analysis identifies brain regions activated during rectal distension in irritable bowel syndrome. Gastroenterology 2011;140:91–100.
- Grover M, Drossman DA. Psychopharmacologic and behavioral treatments for functional gastrointestinal disorders. Gastrointest Endosc Clin N Am 2009;19:151–170.
- Longstreth GF, Thompson WG, Chey WD, et al. Functional bowel disorders. Gastroenterology 2006;130:1480–1491.
- Carnett JB. Intercostal neuralgia as a cause of abdominal pain and tenderness. Surg Gynecol Obstet 1926;42:625.
- Behar J, Corazziari E, Guelrud M, et al. Functional gallbladder and sphincter of Oddi disorders. Gastroenterology 2006;130:1498–1509.
- Tack J, Talley NJ, Camilleri M, et al. Functional gastroduodenal disorders. Gastroenterology 2006;130:1466–1479.
- American Psychiatric Association. DSM-5 diagnostic and statistical manual of mental disorders. Washington, DC: American Psychiatric Publishing, Inc., 2013.
- Butler SF, Budman SH, Fernandez KC, et al. Development and validation of the Current Opioid Misuse Measure. Pain 2007;130:144–156.
- Drossman DA, Camilleri M, Mayer EA, et al. AGA technical review on irritable bowel syndrome. Gastroenterology 2002;123:2108–2131.
- Creed F, Levy R, Bradley L, et al. Psychosocial aspects of functional gastrointestinal disorders. In: Drossman DA, Corazziari E, Delvaux M, Spiller RC, Talley NJ, Thompson WG, Whitehead WE (eds). Rome III: The functional gastrointestinal disorders. 3rd edition. McLean, VA: Degnon Associates, Inc., 2006;295–368.
- Drossman DA. Severe and refractory chronic abdominal pain: treatment strategies. Clin Gastroenterol Hepatol 2008;6:978–982.
- Grunkemeier DM, Cassara JE, Dalton CB, et al. The narcotic bowel syndrome: clinical features, pathophysiology, and management. Clin Gastroenterol Hepatol 2007;5:1126–1139.
- Drossman DA, Morris CB, Edwards H, et al. Diagnosis, characterization, and 3-month outcome after detoxification of 39 patients with narcotic bowel syndrome. Am J Gastroenterol 2012;107:1426–1440.
- Drossman D, Szigethy E. The narcotic bowel syndrome: A recent update. Am J Gastroenterol 2014 (Suppl);2:22–30.
- Kurlander JE, Drossman DA. Diagnosis and treatment of narcotic bowel syndrome. Nature Reviews. Gastroenterol Hepatol 2014;11:410–418.
- Szigethy E, Schwartz M, Drossman D. Narcotic bowel syndrome and opioid-induced constipation. Curr Gastroenterol Rep 2014;16:410–422.
- Camilleri M, Drossman DA, Becker G, Webster LR, Davies AN, Mawe GM. Emerging treatments in neurogastroenterology: a multidisciplinary working group consensus statement on opioid-induced constipation. Neurogastroenterol Motil 2014;26:1386–1395.
You must be logged in with a subscription to access this page. Click here to login.